Merck News Room April 6, 2011 WHITEHOUSE STATION, NJ – April 6, 2011 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has completed its review of Merck’s supplemental biologics license application (sBLA) for an indication to use GARDASIL [Human Papillomavirus […]
SANE Vax, Inc. presents global concerns about HPV vaccines at the British Society for Ecological Medicine Conference
Natural News Monday, April 04, 2011 Posted by: Rosemary Mathis, Director of SANE VAX, INC. Written by: Leslie Carol Botha April 5, 2011 On March 11, Freda Birrell, Scotland, and Leslie Carol Botha, U.S., participated in the British Society for Ecological Medicine Spring Scientific Meeting in London, titled: ‘A tablet a day keeps the patient […]
November 16-17, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Summary Minutes
Food and Drug Administration Center for Biologics Evaluation and Review SUMMARY MINUTES VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE November 16 – 17, 2010 Silver Spring Hilton, Silver Spring, MD The Chair, Dr. Jack Stapleton, called the Meeting of the Vaccines and Related Biological Products Advisory Committee to order at 9:00 a.m. EST on November […]
Behind the Scenes: The Evolution of an HPV Industry
By Norma Erickson, President of SaneVax Inc. The first papillomavirus was discovered in the 1930’s by Dr. Richard E. Shope. It was the cottontail rabbit papillomavirus, or the Shope papillomavirus, which occurred in warts that frequently developed into cancerous tumors1. Dr. Shope was able to isolate the virus, inject it into other rabbits and produce […]
A little protection can be a dangerous thing
By Jacky Jones SECOND OPINION: HPV vaccination programme makes no economic sense, writes JACKY JONES THE HSE is offering a new human papilloma virus (HPV) vaccination programme to young girls in first and second year at secondary school. The organisation plans to immunise more than 46,000 girls in 2011, at a cost of €4 million. Does […]
- « Previous Page
- 1
- …
- 119
- 120
- 121
- 122
- 123
- …
- 240
- Next Page »